Cardiome Pharma Corp. operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Cardiome Pharma Corp. with three other
companies in this sector in Canada:
Acerus Pharmaceuticals Corporation
sales of 32.35 million Canadian Dollars [US$24.18 million]
(37.07 million Canadian Dollars [US$27.71 million]
of which 100%
was Therapeutic Peptides), and
Nuvo Pharmaceuticals Inc
(27.04 million Canadian Dollars [US$20.21 million]
Cardiome Pharma Corp. reported sales of C$33.37 million (US$24.94 million)
December of 2016.
increase of 23.9%
versus 2015, when the company's sales were C$26.93 million.